Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
about
Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in miceMultiple receptors contribute to the behavioral effects of indoleamine hallucinogens.Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 yearsRecent advances in the neuropsychopharmacology of serotonergic hallucinogensEffects of psilocybin on time perception and temporal control of behaviour in humansMetabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuascaBehavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.PsychedelicsEnhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophrenia.Brain mechanisms of hallucinogens and entactogens.Noncompetitive inhibition of indolethylamine-N-methyltransferase by N,N-dimethyltryptamine and N,N-dimethylaminopropyltryptamine.Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin.Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors.The hallucinogenic world of tryptamines: an updated review.Neuropharmacology of N,N-dimethyltryptamineResearch on acute toxicity and the behavioral effects of methanolic extract from psilocybin mushrooms and psilocin in micePsilocybin-induced stimulus control in the rat.Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.Chemistry and Structure-Activity Relationships of Psychedelics.Psilocybin for treating substance use disorders?Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance.Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.Availability of websites offering to sell psilocybin spores and psilocybin.Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia.Effect of Hallucinogens on Unconditioned Behavior.Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample.Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning.Binding properties of dipropyltryptamine at the human 5-HT1a receptor.Unifying Theories of Psychedelic Drug Effects.N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function
P2860
Q24594834-E548E282-F545-4069-850A-ED9F33BB2063Q24620764-C4B78A14-9F03-4A22-84C2-CC812D0D0FF0Q26746137-6CAF06B6-6533-4452-B954-B535C4CDFB4CQ27027381-13392D88-28C3-4EE2-A213-076507EAC5B2Q28241533-C2E3C13B-D101-4056-B84C-3B98645DB084Q28264811-378241EC-75C7-4A4D-A455-636196362489Q30358201-F2B64745-BB93-4043-9CAC-DA6E88D4DEDDQ30359998-2B267FBB-B065-49AC-817D-04F8E368124CQ30445688-083DB8BA-0C3F-4FF8-BC92-194F9A6E836AQ30473430-0D786E5C-C210-44B7-9B2E-D4F8B8B1F4CFQ33629953-07A3EF0C-8DEA-4479-8014-051349BA7BD5Q34087847-29CF00B0-AB72-4095-9E20-5C0B11E3E667Q34390441-EABEA486-F7B3-48F3-8EB4-658A8A2EE4F4Q34465159-E2C7524F-DA26-4910-8FB8-2A88E8C977D6Q34471834-9AB9A4C7-5C05-4E93-BFDC-380FC4AB61E1Q34524116-4A01A912-0F0B-4952-87DD-1398A3E0A400Q35564012-83DBFCC0-3FB8-4200-9364-DEDC4F791EF0Q36023615-B61416AC-2B8A-4496-9A6B-BF32411D37CEQ36569714-57A49C60-8EAC-49BB-A143-F02DCB3500CCQ38378860-B4086292-17B9-4E10-95B0-3804FD56307AQ38841130-C09CB8F3-B4F8-447F-9DC2-2665ADCDD089Q38967632-DCB8B65D-E3CB-4F70-BFD2-50FFE8D3C65BQ39079288-23933A2F-8EFF-428E-A1FA-DB3488DDD5CFQ39290453-7FF60ED7-8724-4515-A431-A0BA2FE94FC8Q43226439-C428FC5B-2500-45C3-97D7-436B7D19C7C8Q44259252-8896CD34-1EF0-4AC9-98EF-9456D0E78DF6Q45279141-1D145D06-BD34-4B33-8BB8-7D60C6288521Q45383954-1D213B5B-5AC6-4027-B683-322629352C4BQ45827002-8AC7DE54-3638-415A-B3EF-631D31E779F0Q46484531-E1FA4036-5672-4C8A-AEDD-974C62FE10D9Q52641641-7678B15F-32E6-4303-84B8-0029102F57CEQ57075471-44434551-EBEA-4B44-A30C-B93F72DB2E3C
P2860
Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
description
1990 nî lūn-bûn
@nan
1990 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մարտին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
@ast
Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
@en
Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
@nl
type
label
Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
@ast
Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
@en
Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
@nl
prefLabel
Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
@ast
Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
@en
Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
@nl
P2093
P1433
P1476
Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
@en
P2093
P356
10.1016/0028-3908(90)90001-8
P407
P577
1990-03-01T00:00:00Z